Mary E. Gordinier

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

Robert L. Coleman, Domenica Lorusso, Christine Gennigens et al. · The Lancet Oncology · 2021 · 367 citations

Tisotumab Vedotin, Cervical Cancer, Metastatic Cervical Cancer +8

Adnexal Masses in Pregnancy: Surgery Compared With Observation

Kathleen M. Schmeler, William W. Mayo-Smith, Jeffrey F. Peipert et al. · Obstetrics and Gynecology · 2005 · 317 citations

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 272 citations · Full text

The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients

Laurent Brard, Sherry Weitzen, Suzanne L. Strubel-Lagan et al. · Gynecologic Oncology · 2006 · 89 citations

Nutrition, Total Parenteral Nutrition, Nutritional Requirement +11

Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma☆

Cyril W. Helm, L. Randall-Whitis, R MARTINIII et al. · Gynecologic Oncology · 2006 · 88 citations

Surgical Oncology, Gynecological Surgery, Medicine +8